Jubilant Therapeutics
As of the edition of 20 October 2026, Jubilant Therapeutics runs 2 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Total | 2 |
Where its trials are
- Cancer: 2 trials led
- Blood and lymph: 1 trials led
- Nervous system: 1 trials led